Predicting health utilities using health administrative data: leveraging survey-linked health administrative data from Ontario, Canada
Niu Y, Begen N, Zou G, Sarma S. Appl Health Econ Health Policy. 2025; Feb 6 [Epub ahead of print].
Publications
Improving epilepsy care in Ontario, Canada: the impact of a provincial strategy for epilepsy care
Antaya TC, Carter B, Shariff SZ, Boissé Lomax L, Donner E, Nylen K, Snead OC 3rd, Burneo JG. Can J Neurol Sci. 2025; Jan 31 [Epub ahead of print].
Secondary stroke prevention in Ontario: a population-based cohort study
Fleet JL, Kapral MK, Carter B, Frisbee S, Lam M, Shariff SZ. Can J Neurol Sci. 2025; Jan 27 [Epub ahead of print].
Processes of obstetrical care and outcomes among Ontario physicians versus non-physicians: a population-based study
Simpson AN, Sutradhar R, McArthur E, Cusimano MC, Baxter NN. BMJ Open. 2024; 14(12):e091312.
Interprofessional team-based primary care practice and preventive cancer screening: evidence from family health teams in Ontario, Canada
Bai Y, Reid J, Habbous S, Devlin RA, Jaakkimainen L, Sarma S. Eur J Health Econ. 2024; Dec 9 [Epub ahead of print].
Co-prescription of low-dose methotrexate and trimethoprim-sulfamethoxazole and the 30-day risk of death among older adults: a cohort study
Sadeghi H, Ahmadi F, McArthur E, Sontrop JM, Abdullah SS, Urquhart BL, Kim RB, Muanda FT. Br J Clin Pharmacol. 2024; Dec 8 [Epub ahead of print].
Randomized trials using provincial health numbers for group assignment
Garg AX, Dixon SN, Ma C, Basile E, Luo B, De Melo MN, Molnar AO, Poonai N, Schull MJ, Silver SA, Sontrop JM, Zwarenstein M, Roshanov P. Can J Kidney Health Dis. 2024; 11:20543581241304510.
Rhabdomyolysis and sodium-glucose-linked transport inhibitors in patients taking statins
Harel Z, Jeyakumar N, Smith G, Ray JG, Clemens KK, Juurlink DN. JAMA Netw Open. 2024; 7(11):e2446641.
Prevalence, characteristics, and outcomes of people with a high body mass index across the kidney disease spectrum: a population-based cohort study
Sahi G, Reid J, Moist L, Chiu M, Vinson A, Stranges S, Naylor K, Zhu Y, Clemens KK. Can J Kidney Health Dis. 2024; 11:20543581241293199.
Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease
Olar P, Garg AX, Weir MA, Ahmadi F, McArthur E, Lam NN, Sontrop JM, Muanda FT. Pharmacol Res Perspect. 2024; 12(6):e70028.